2025 QC Micro Summit Recap

Behind the scenes of the microbiology industry's premier event

As a former microbiologist who once chased down excursions and read EM plates, and now as a strategic marketer behind the scenes, planning and co-leading the QC Micro Summit has become a personal passion.

The 2025 QC Micro Summit held March 25-27th in Charleston, SC, showcased precisely why that passion exists: inspiring innovation, meaningful collaboration, and solutions that microbiologists can apply back in their labs immediately.

Day 1: Charting the Course for QC Innovation

After welcoming attendees and encouraging everyone to reflect on their purpose for attending, we set a clear tone: The future of QC microbiology is created in rooms like this—with the right people, the right questions, and a spirit of genuine curiosity.

Christoph Hansy (Takeda Pharmaceuticals) kicked off Day 1 with “The Next Frontier in QC Microbiology,” blending vision with realism on adopting futuristic lab technologies. Jay Bolden (Eli Lilly) seamlessly followed, illustrating the evolution of endotoxin testing from traditional LAL methods to modern recombinant assays. His session reminded us that innovation thrives even in the most regulated spaces.

Adding to the mix, Mehmet Davrandi (Procter & Gamble) virtually challenged perceptions, proving sterile and non-sterile environments share more microbiological common ground than many assume. Gwen Kuehl (Pfizer) rounded out the morning showcasing real-world improvements from automating endotoxin testing—efficiencies QC labs dream about.

The afternoon’s interactive roundtables turned energy into action, with sessions like “Big Thinking for Micro Solutions” sparking lively, practical discussions.

A special highlight for me personally was our first-ever “Beyond the Bench” fireside chat with industry legend Phil Duncanson (AstraZeneca). Phil’s reflections on his career—stressing that lateral moves and executive presence are just as valuable as vertical leaps—left attendees (and me!) inspired and motivated.

Day 2: Sustainability, Data, and Contamination Control

Day 2 started memorably, recognizing Dr. James Cooper’s pioneering work in endotoxin testing—an honor highlighting our industry’s impactful legacy. Steve Vitale (GSK) captivated attendees with practical ways QC labs can drive sustainability through My Green Lab principles, offering approachable yet powerful ideas to make an immediate environmental difference.

Next up, Carl Patterson (Latitude Pharmaceuticals) demonstrated the transformative power of Python for microbiological data analytics. Carl’s session clearly resonated with attendees eager to trade Excel nightmares for sleek dashboards and real-time trend analyses.
Contamination investigations took center stage as Morgan Polen (Microrite) offered crucial insights on overlooked factors behind sterility failures, highlighting the critical importance of robust, holistic investigations. Laurie Boyd (Alkermes) further deepened that insight by sharing lessons learned from revising investigation SOPs amid a sterility crisis—a relatable scenario to many attendees.

The afternoon product demos showcased transformative solutions like Charles River’s Endosafe Nexus 200, Celsis ATP Bioluminescence, and Accugenix’s enhanced environmental tracking—tools poised to redefine QC lab efficiency.

Watch: Highlights from Day 2 of QC Micro Summit

Ending the day was another standout “Beyond the Bench” session with Ziva Abraham (Microrite), whose relentless pursuit of knowledge underscored her powerful message: “Knowledge is power.” Attendees left energized to apply that mantra directly to their professional journeys.

Day 3: From Insights to Action

The final day kept the momentum going with Joanny Salvas (Pfizer) and Yvonne Bos (Charles River) connecting microbiological expertise with project management, cleverly comparing long-distance running to strategic planning—a fresh take that resonated strongly.

Joe Wolinski (Baxter International) walked attendees through navigating validation and regulatory filing complexities using Baxter’s real-world experience with rapid sterility testing as a guiding example.

Erika Pfeiler (Valsource) then demystified regulatory submission intricacies, equipping attendees to confidently manage post-approval changes, while Jessica Hankins (Bristol Myers Squibb) wrapped the sessions by providing pragmatic insights on recombinant cascade reagent implementation, stressing the value of analyst input and vendor assessment.

Our final “Beyond the Bench” panel emphasized the vibrant diversity of careers in QC Micro, reinforcing themes of innovation, resilience, and continuous learning that defined the entire summit.

Closing Thoughts

The 2025 QC Micro Summit exceeded my expectations—not just as one of its organizers, but as a former microbiologist who still deeply resonates with the everyday challenges faced by attendees. Witnessing the enthusiasm, knowledge exchange, and connections forged over three dynamic days reminded me precisely why this event matters.

Stay tuned as we build upon these successes. We can’t wait to welcome you all again next year for even more insights, innovation, and inspiration at the 2026 QC Micro Summit!

The Micro Keeps You in The Know
You don't need an agar plate to grow your microbial knowledge. Get industry updates, articles and other resources delivered straight to your inbox each month.
Subscribe